Skip to main content
Premium Trial:

Request an Annual Quote

GeneDx to Launch Clinical Exome Sequencing Test in Early 2012

Premium

GeneDx is planning an early 2012 launch for XomeDx, a clinical exome sequencing test, the Bio-Reference Laboratories subsidiary said this week.

The test, expected to be available starting in January, is aimed at patients with genetic diseases where more targeted genetic tests were unable to provide a molecular diagnosis.

The Gaithersburg, Md.-based company will run the test in its CLIA-certified laboratory and will apply its clinical expertise, technology, and analysis of family data to identify the genetic defect. It will generate test reports that "will be simple to understand for the clinician, patient, and their family."

The test would join a similar offering from Ambry Genetics, which last week launched its Clinical Diagnostic Exome test for patients with undiagnosed or difficult-to-diagnose genetic disorders (CSN 10/5/2011).

The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.